DiseaseID 4648
多发性硬化
disease
NCI2016_NICHD_1602D:An autoimmune demyelinating disease characterized by a relapsing-remitting or progressive pattern of central nervous system impairment.|NCI2016_NCI-GLOSS_1602D:A disorder of the central nervous system
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 1Experiment: 6Formula: 1Herb: 3Symptom: 12Target: 25Links: 47
Arranging relationship network...
Record Fields
Scalar fields from the final disease record.
- Disease Id
- 4648
- Core Entity Id
- 61027
- Source Entity Count
- 1
- Preferred Name
- Multiple Sclerosis
- Name Cn
- 多发性硬化
- Name Pinyin
- Duo Fa Xing Ying Hua
- Name En
- Multiple Sclerosis
- Name Latin
- Bilingual Status
- complete
- Disease Type
- disease
- Umls Disease Type
- Disease or Syndrome
- Disgenet Type
- disease
- Mesh Class
- Immune System Diseases; Nervous System Diseases
- Do Class
- disease of anatomical entity
- Hpo Class
- Mesh Class Name
- Immune System Diseases; Nervous System Diseases
- Hpo Class Name
- Do Class Name
- disease of anatomical entity
- Disease Definition
- NCI2016_NICHD_1602D:An autoimmune demyelinating disease characterized by a relapsing-remitting or progressive pattern of central nervous system impairment.|NCI2016_NCI-GLOSS_1602D:A disorder of the central nervous system marked by weakness, numbness, a loss of muscle coordination, and problems with vision, speech, and bladder control. Multiple sclerosis is thought to be an autoimmune disease in which the body's immune system destroys myelin. Myelin is a substance that contains both protein and fat (lipid), serving as a nerve insulator and helping in the transmission of nerve signals.|NCI2016_02D:A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.|MSH2017_2016_08_12:An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)|MEDLINEPLUS_20151021:<p>Multiple sclerosis (MS) is a nervous system disease that affects your brain and spinal cord. It damages the myelin sheath, the material that surrounds and protects your nerve cells. This damage slows down or blocks messages between your brain and your body, leading to the symptoms of MS. They can include</p> <ul> <li>Visual disturbances</li> <li>Muscle weakness</li> <li>Trouble with coordination and balance</li> <li>Sensations such as numbness, prickling, or "pins and needles" </li> <li>Thinking and memory problems</li> </ul> <p>No one knows what causes MS. It may be an autoimmune disease, which happens when your immune system attacks healthy cells in your body by mistake. Multiple sclerosis affects women more than men. It often begins between the ages of 20 and 40. Usually, the disease is mild, but some people lose the ability to write, speak, or walk.</p> <p>There is no single test for MS. Doctors use a medical history, physical exam, neurological exam, MRI, and other tests to diagnose it. There is no cure for MS, but medicines may slow it down and help control symptoms. Physical and occupational therapy may also help.</p> <p >NIH: National Institute of Neurological Disorders and Stroke</p>|CSP2006:chronic disease characterized by presence of numerous areas of demyelination in the central nervous system with symptoms such as weakness, incoordination, paresthesis, and speech disturbances; the etiology is unknown.
- Version
- v2
- Suppressed
- No
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Multiple Sclerosis
Role
preferred
Name
Multiple Sclerosis, Acute Fulminating
Role
preferred
Cross References
Trusted external identifiers retained for this final record.
Herb
HBDIS001992HBDIS011234
Me Sh
D009103
Umls
C0026769
Icd10
G35
Sym Map
SMDE11153
Do Class
DOID:7
Dis Ge Net
C0026769C0751324
Umls Sty
T047
Me Sh Class
C10C20
Etcm Disease
Multiple Sclerosis
Tcmbank Disease
18129295849579
Itcmdb Generated
ITX-DISEASE-0E507D9C0652ITX-DISEASE-329F917D75F1
Attributes
Merged source attributes and domain-specific metadata.
Version
v2
Suppress
0
Page Title
Disease Multiple Sclerosis Details page
Do Class Name
disease of anatomical entity
Disease Type
disease
Do Disease Class
disease of anatomical entity
Umls Disease Type
Disease or Syndrome
Basic Information
Disease Name
Multiple Sclerosis
Global Category
Genetic diseases;Rare diseases
Anatomical Category
Immune diseases;Neuronal diseases
Disease Definition
NCI2016_NICHD_1602D:An autoimmune demyelinating disease characterized by a relapsing-remitting or progressive pattern of central nervous system impairment.|NCI2016_NCI-GLOSS_1602D:A disorder of the central nervous system marked by weakness, numbness, a loss of muscle coordination, and problems with vision, speech, and bladder control. Multiple sclerosis is thought to be an autoimmune disease in which the body's immune system destroys myelin. Myelin is a substance that contains both protein and fat (lipid), serving as a nerve insulator and helping in the transmission of nerve signals.|NCI2016_02D:A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.|MSH2017_2016_08_12:An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)|MEDLINEPLUS_20151021:<p>Multiple sclerosis (MS) is a nervous system disease that affects your brain and spinal cord. It damages the myelin sheath, the material that surrounds and protects your nerve cells. This damage slows down or blocks messages between your brain and your body, leading to the symptoms of MS. They can include</p> <ul> <li>Visual disturbances</li> <li>Muscle weakness</li> <li>Trouble with coordination and balance</li> <li>Sensations such as numbness, prickling, or "pins and needles" </li> <li>Thinking and memory problems</li> </ul> <p>No one knows what causes MS. It may be an autoimmune disease, which happens when your immune system attacks healthy cells in your body by mistake. Multiple sclerosis affects women more than men. It often begins between the ages of 20 and 40. Usually, the disease is mild, but some people lose the ability to write, speak, or walk.</p> <p>There is no single test for MS. Doctors use a medical history, physical exam, neurological exam, MRI, and other tests to diagnose it. There is no cure for MS, but medicines may slow it down and help control symptoms. Physical and occupational therapy may also help.</p> <p >NIH: National Institute of Neurological Disorders and Stroke</p>|CSP2006:chronic disease characterized by presence of numerous areas of demyelination in the central nervous system with symptoms such as weakness, incoordination, paresthesis, and speech disturbances; the etiology is unknown.
Me Sh Disease Class
Immune System Diseases; Nervous System Diseases
Dis Ge Net Disease Type
disease
Disease Class Name Me Sh
Immune System Diseases; Nervous System Diseases
Umls Semantic Type Name
Disease or Syndrome